Aquestive Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AQST and other ETFs, options, and stocks.

About AQST

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. 

CEO
Daniel Barber
CEODaniel Barber
Employees
142
Employees142
Headquarters
Warren, New Jersey
HeadquartersWarren, New Jersey
Founded
2004
Founded2004
Employees
142
Employees142

AQST Key Statistics

Market cap
417.18M
Market cap417.18M
Price-Earnings ratio
-7.49
Price-Earnings ratio-7.49
Dividend yield
—
Dividend yield—
Average volume
1.21M
Average volume1.21M
High today
$4.50
High today$4.50
Low today
$4.20
Low today$4.20
Open price
$4.45
Open price$4.45
Volume
2.51M
Volume2.51M
52 Week high
$5.80
52 Week high$5.80
52 Week low
$2.12
52 Week low$2.12

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own AQST. This list is generated using Robinhood data, and it’s not a recommendation.
Assertio
SNDL
Agenus
MiNK Therapeutics
Tilray Brands
Catalyst Pharmaceuticals
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.